Tag Archives: science

New Study on BRCA Mutation in Women with Ovarian Cancer

A new study of 1,001 women with ovarian cancer found that 14% of them carried a BRCA1 or BRCA2 mutation. However, 44% of those women did not have a family … Continue reading 

Posted in News | Also tagged , , , , , , , | Leave a comment

An Update on PARP Inhibitors

Development of PARP inhibitors, which appear to work best in women with BRCA mutations, has faced setbacks recently. An article reviews the data, good and bad, about PARP inhibitors. The … Continue reading 

Posted in News | Also tagged , , , , , | Leave a comment

Study Shows Some Benefit to Second Debulking Surgery Followed by HIPEC

A study of 56 patients in Italy who had ovarian cancer showed that women with recurrent ovarian cancer benefited from a second debulking surgery followed by HIPEC. HIPEC, or hyperthermic … Continue reading 

Posted in News | Also tagged , , , , | Leave a comment

Depo-Provera Shown to Reduce Risk of Ovarian Cancer

A large body of data shows that use of oral contraceptives reduces the risk of developing ovarian cancer. A new study of approximate 1400 women in Thailand suggests that the … Continue reading 

Posted in News | Also tagged , , | Leave a comment

Removing Fallopian Tubes Reduces Risk of Ovarian Cancer

Based on data showing that removing a woman’s fallopian tubes removes her risk of developing ovarian cancer, doctors are now urging women who are having their tubes tied to have … Continue reading 

Posted in News | Also tagged , , , , , | Leave a comment

Decision Tool for women with BRCA Mutations Released

The Stanford Medicine Cancer Clinic has designed an online tool for women with a BRCA mutation. These genetic mutations increase a woman’s risk of developing breast and ovarian cancer. The … Continue reading 

Posted in News | Also tagged , , , , | Leave a comment

Coffee and/or Tea Intake Not Associated with Ovarian Cancer

An analysis of more than 330,000 European women found no evidence that coffee and/or tea intake had any effect on the risk of developing ovarian cancer. The abstract can be … Continue reading 

Posted in News | Also tagged , , , | Leave a comment

Phase III Trial of Bevacizumab with Chemotherapy

A Phase III trial of bevacizumab (Avastin) with gemcitabine + carboplatin versus gemcitabine + carboplatin in women with ovarian cancer showed the bevacizumab arm to improve progression free survival (PFS). … Continue reading 

Posted in News | Also tagged , , , , , | Leave a comment

Why We Need a Screening Test (CNN)

Otis Brawley, Chief Medical Officer of the American Cancer Society, talked to CNN about recent recommendations against screening for ovarian cancer. Dr. Brawley noted that the tools we currently have … Continue reading 

Posted in News | Also tagged , , , | Leave a comment

Height, Weight, Linked to Ovarian Cancer Risk

Both height and weight are linked to according to a new meta-analysis. The data examined a total of 25,157 women with ovarian cancer and 81,311 women without ovarian cancer. The … Continue reading 

Posted in News | Also tagged , | Leave a comment

Olaparib shows improvement in PFS but not OS, Thus Far

Olaparib, a PARP inhibitor, showed an 3.6 month improvement in progression free survival (PFS) in women with platinum sensitive recurrent ovarian cancer. However, based on the interim analsis, there is … Continue reading 

Posted in News | Also tagged , , , | Leave a comment

Study Argues for Increased Use of PARP Inhibitors

A study from the Oregon Health & Science University suggests that women who have a recurrence of ovarian cancer would benefit from PARP inhibitors, now being tested in women with hereditary … Continue reading 

Posted in News | Also tagged , , , | Leave a comment